To confirm the inhibitory effect of SCARB2 deletion on HCC progression, we knocked out SCARB2 in HCCLM3 cells using lentivirus-mediated delivery of CRISPR-Cas9 system components. The gene discussed is SCARB2; the disease is hepatocellular carcinoma.